Vrtx stock price performance this week aligns with
VRTX stock price performance this week aligns with sector-wide biotech gains, aided by lower interest rate expectations. Vertex's stable profit margins and steady pipeline development reinforce bullish forecasts toward mid-$440s in the near term. At $380 per share, Vertex Pharmaceuticals trades at 19.7x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it’s free . Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report VRTX stock price this week demonstrates relative strength compared to S&P healthcare index, boosted by sector rotation into high-growth biotech plays. Analysts maintain overweight ratings with upward bias.
Return this item for free
We offer easy, convenient returns with at least one free return option: no shipping charges. All returns must comply with our returns policy.
Learn more about free returns.- Go to your orders and start the return
- Select your preferred free shipping option
- Drop off and leave!